Brophy Sinead, Burrows Claire L, Brooks Caroline, Gravenor Michael B, Siebert Stefan, Allen Stephen J
School of Medicine, Swansea University, Swansea, Wales SA2 8PP, UK.
BMC Musculoskelet Disord. 2008 Jan 11;9:4. doi: 10.1186/1471-2474-9-4.
The clinical effectiveness of complementary and alternative medicines (CAMs) is widely debated because of a lack of clinical trials. The internet may provide an effective and economical approach for undertaking randomised controlled trials (RCTs) of low-risk interventions. We investigated whether the internet could be used to perform an internet-based RCT of a CAM fulfilling the revised CONSORT (Consolidated Standards of Reporting Trials) statement quality checklist for reporting of RCTs. A secondary aim was to examine the effect of probiotics compared to placebo in terms of well-being over 12 weeks.
People aged > or =18 years with confirmed spondyloarthropathy living in the United Kingdom with internet access were invited to participate in an internet-based RCT of probiotic compared to placebo for improving well-being and bowel symptoms. The intervention was a probiotic containing 4 strains of live bacteria or identical placebo taken by mouth daily for 3 months. The primary outcome measure was the performance of the trial according to the revised CONSORT statement.
147 people were randomised into the trial. The internet-based trial of the CAM fulfilled the revised CONSORT statement such as efficient blinding, allocation concealment, intention to treat analysis and flow of participants through the trial. Recruitment of the required number of participants was completed in 19 months. Sixty-five percent (96/147) completed the entire 3 months of the trial. The trial was low cost and demonstrated that in an intention to treat analysis, probiotics did not improve well-being or bowel symptoms.
The internet-based RCT proved to be a successful and economical method for examining this CAM intervention. Recruitment, adherence and completion rate were all similar to those reported with conventional RCTs but at a fraction of the cost. Internet-based RCTs can fulfil all the criteria of the revised CONSORT statement and are an appropriate method for studying low-risk interventions.
ISRCTN36133252.
由于缺乏临床试验,补充和替代医学(CAMs)的临床疗效备受争议。互联网可能为开展低风险干预措施的随机对照试验(RCTs)提供一种有效且经济的方法。我们调查了互联网是否可用于开展一项符合修订后的CONSORT(试验报告统一标准)声明质量清单要求的CAM基于互联网的RCT。次要目的是在12周内比较益生菌与安慰剂在幸福感方面的效果。
邀请年龄≥18岁、确诊患有脊柱关节病且居住在英国并能上网的人群参与一项基于互联网的RCT,比较益生菌与安慰剂对改善幸福感和肠道症状的效果。干预措施为每天口服含有4种活菌株的益生菌或相同的安慰剂,持续3个月。主要结局指标是根据修订后的CONSORT声明评估试验的执行情况。
147人被随机纳入试验。基于互联网的CAM试验符合修订后的CONSORT声明,如有效设盲、分配隐藏、意向性分析以及参与者在试验中的流程。在19个月内完成了所需数量参与者的招募。65%(96/147)的参与者完成了整个3个月的试验。该试验成本较低,且在意向性分析中表明,益生菌并未改善幸福感或肠道症状。
基于互联网的RCT被证明是检验这种CAM干预措施的一种成功且经济的方法。招募、依从性和完成率均与传统RCT报告的情况相似,但成本仅为其一小部分。基于互联网的RCT能够满足修订后的CONSORT声明的所有标准,是研究低风险干预措施的一种合适方法。
ISRCTN36133252。